Hay D W, Luttmann M A, Muccitelli R M, Goldie R G
Department of Pulmonary Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406, USA.
Naunyn Schmiedebergs Arch Pharmacol. 1999 May;359(5):404-10. doi: 10.1007/pl00005368.
Tension and phosphatidyl inositol (PI) turnover experiments were conducted to investigate the receptors and signal transduction pathways responsible for contractions elicited by endothelin (ET) ligands in human bronchus. Nicardipine (1 microM), the L-type calcium channel inhibitor, or incubation in Ca2+-free medium, produced marked inhibition of contractions to the ET(B) receptor-selective agonist, sarafotoxin S6c, and especially those induced by KCl. In contrast, Ca2+-free medium was without appreciable effect against contraction produced by endothelin-1 (ET-1), the non-selective ET(A) and ET(B) receptor agonist. In Ca2+-free medium, ryanodine (10 microM), which inhibits intracellular calcium mobilization, reduced sarafotoxin S6c- and ET-1-induced responses, but was without effect on responses to KCl. Similarly, nickel chloride (Ni2+; 1 mM) caused marked inhibition of contractions induced by sarafotoxin S6c or ET-1, but had no significant effect on KCI concentration-response curves. The mixed ET(A)/ET(B) receptor antagonist SB 209670 (3 microM) inhibited responses to sarafotoxin S6c and ET-1 such that concentration-response curves were shifted rightward, at the 30% maximum response level, by 10.0- and 3.8-fold, respectively, whereas BQ-123 (3 microM), the ET(A) receptor antagonist, was without effect on responses induced by either agonist. ET-1 (1 nM-0.3 microM) caused a concentration-dependent stimulation of PI turnover, whereas sarafotoxin S6c (0.3 nM-0.1 microM) induced only small and variable increases, except at the highest concentration. The increase in PI turnover evoked by ET-1 was inhibited by SB 209670 (3 microM), and also by BQ-123 (3 microM). This is consistent with linkage of ET(A) receptors to activation of inositol phosphate generation in human bronchial smooth muscle cells. Collectively, the data suggest that differences exist in the relative contributions of intracellular and extracellular Ca2+ mobilization mechanisms elicited by ET(A) and ET(B) receptor activation. Thus, sarafotoxin S6c-induced, ET(B) receptor-mediated contraction in human bronchial smooth muscle appears to be dependent, in part, upon extracellular Ca2+, although a significant component of the response was also mediated by intracellular Ca2+ release, including from ryanodine-sensitive stores. ET(A) receptor-mediated contraction of human airway smooth muscle was activated largely via the release of intracellular Ca2+.
进行了张力和磷脂酰肌醇(PI)周转实验,以研究负责内皮素(ET)配体在人支气管中引发收缩的受体和信号转导途径。L型钙通道抑制剂尼卡地平(1 microM)或在无钙培养基中孵育,可显著抑制对ET(B)受体选择性激动剂沙拉毒素S6c的收缩反应,尤其是对氯化钾诱导的收缩反应。相比之下,无钙培养基对非选择性ET(A)和ET(B)受体激动剂内皮素-1(ET-1)引起的收缩没有明显影响。在无钙培养基中,抑制细胞内钙动员的ryanodine(10 microM)可降低沙拉毒素S6c和ET-1诱导的反应,但对氯化钾反应无影响。同样,氯化镍(Ni2+;1 mM)可显著抑制沙拉毒素S6c或ET-1诱导的收缩,但对氯化钾浓度-反应曲线无显著影响。ET(A)/ET(B)混合受体拮抗剂SB 209670(3 microM)抑制对沙拉毒素S6c和ET-1的反应,使浓度-反应曲线分别在30%最大反应水平向右移动10.0倍和3.8倍,而ET(A)受体拮抗剂BQ-123(3 microM)对两种激动剂诱导的反应均无影响。ET-1(1 nM - 0.3 microM)引起PI周转的浓度依赖性刺激,而沙拉毒素S6c(0.3 nM - 0.1 microM)仅诱导微小且变化不定的增加,除了在最高浓度时。ET-1引起的PI周转增加被SB 209670(3 microM)以及BQ-123(3 microM)抑制。这与ET(A)受体与人类支气管平滑肌细胞中肌醇磷酸生成的激活相联系是一致的。总体而言,数据表明ET(A)和ET(B)受体激活引发的细胞内和细胞外钙动员机制的相对贡献存在差异。因此,沙拉毒素S6c诱导的、ET(B)受体介导的人支气管平滑肌收缩似乎部分依赖于细胞外钙,尽管反应的一个重要组成部分也由细胞内钙释放介导,包括来自ryanodine敏感储存库的钙释放。ET(A)受体介导的人气道平滑肌收缩主要通过细胞内钙的释放而激活。